Using contact precautions in addition the to the basic level of infection control might not limit the spread of drug-resistant Enterobacteriaceae, according to work presented at ECCMID.
Browsing: Disease Area > Bacterial
A new study has investigated whether a 6-day course of antibiotics will give the same outcomes as a 12-day course for treating cellulitis, demonstrating that long-term outcomes may differ.
Research presented at ECCMID outlines the identification and role of novel chromosomal mutations in the development of resistance of Escherichia coli to the broad-spectrum antibiotic fosfomycin.
The results of the MERINO trial have been reported at ECCMID, revealing the combination treatment piperacillin-tazobactam is significantly less effective than meropenem in treating some bloodstream infections.
A new gene identified in P. aeruginosa could act as a prognostic biomarker and treatment target for patients with bloodstream infections.
A study presented at ECCMID has suggested patient outcomes for Gram-negative bacteremia are similar in the case of 7 days and 14 days of antibiotic treatment, suggesting a shorter course length could be beneficial.
E. coli’s internal bomb – the toxin-antitoxin system – could be triggered to make bacteria turn on themselves, offering a new target for antimicrobial approaches in drug design.
A new study has evaluated a point-of-care diagnostic for syphilis and yaws in the Solomon Islands, where previously only serological tests requiring specialist equipment have been available.
Discover our highlights and key takeaways from the Microbiology Society Annual Conference with our Editor, Martha Powell, who runs through some of our favorite talks.